Interactions between Xenobiotics and DME (XEOTIC)
|
Fungicide(s), Herbicide(s) or Insecticide(s) |
Pesticide/Insecticide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Dicrotophos |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01050
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Pesticide/Insecticide |
DME Modulation |
Dicrotophos inhibits the expression of DME PNP |
[1] |
Health or Environmental Toxicant(s) |
Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Benzo(a)pyrene |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen |
DME Modulation |
Benzo(a)pyrene up-regulates the expression of DME PNP |
[2] |
Aflatoxin B1 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen-mycotoxin |
DME Modulation |
Aflatoxin B1 up-regulates the expression of DME PNP |
[3], [4] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 10 Xenobiotics
|
Acetaminophen |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Acetaminophen up-regulates the expression of DME PNP |
[5] |
Arsenic trioxide |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00339
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Arsenic trioxide inhibits the drug-metabolizing activity of DME PNP |
[6] |
Cisplatin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cisplatin up-regulates the expression of DME PNP |
[7] |
Copper sulfate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Copper sulfate up-regulates the expression of DME PNP |
[8] |
Cyclosporine |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cyclosporine up-regulates the expression of DME PNP |
[9] |
Doxorubicin hydrochloride |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00292
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Doxorubicin hydrochloride inhibits the expression of DME PNP |
[10] |
Estradiol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00090
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Estradiol up-regulates the expression of DME PNP |
[11] |
Tretinoin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00253
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Tretinoin inhibits the expression of DME PNP |
[12] |
Valproic acid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00029
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Valproic acid up-regulates the expression of DME PNP |
[13] |
Vorinostat |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00079
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Vorinostat up-regulates the expression of DME PNP |
[14] |
Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Vitamin E |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00547
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Vitamin E inhibits the drug-metabolizing activity of DME PNP |
[15] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Bisphenol A |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01226
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Bisphenol A inhibits the expression of DME PNP |
[16] |
Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
CI-972 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01251
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
CI-972 inhibits the drug-metabolizing activity of DME PNP |
[17] |
Sodium arsenite |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00632
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Sodium arsenite up-regulates the expression of DME PNP |
[18] |
Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
GSK-J4 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01324
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Patented Pharmaceutical Agent |
DME Modulation |
GSK-J4 inhibits the expression of DME PNP |
[19] |
Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Coumestrol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01261
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Investigative Agent |
DME Modulation |
Coumestrol up-regulates the expression of DME PNP |
[20] |
|
|
|
|
|
|